Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_assertion type Assertion NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_head.
- NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_assertion description "[Currently, the most efficacious treatment for malignant gliomas is temozolomide; however, gliomas expressing the DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) are resistant to this drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_provenance.
- NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_assertion evidence source_evidence_literature NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_provenance.
- NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_assertion SIO_000772 18089777 NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_provenance.
- NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_assertion wasDerivedFrom befree-2016 NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_provenance.
- NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_assertion wasGeneratedBy ECO_0000203 NP645915.RAVhK3-_BtoWvyz3sh2gM4ntnkY0-0LSSzGOGj4QvaALM130_provenance.